Cardiac PET

Cardiac PET
Cardiac PET
ICD-10-PCS	C23G, C23Y
OPS-301 code	3-741

Last updated November 30, 2023

Cardiac PET (or cardiac positron emission tomography ) is a form of diagnostic imaging in which the presence of heart disease is evaluated using a PET scanner. Intravenous injection of a radiotracer is performed as part of the scan. Commonly used radiotracers are Rubidium-82, Nitrogen-13 ammonia and Oxygen-15 water.^[1]

Uses

Cardiac PET-CT scan can assess blood flow, metabolism, inflammation, innervation, and receptor density accurately. Besides, it is also useful to detect heart conditions such as coronary artery disease, cardiac amyloidosis, and cardiac sarcoidosis.^[2]

Radiopharmaceuticals

Rubidium-82 is produced from the decay of Strontium-82 through electron capture in a generator. It is used to access the blood vessels supplying the heart. Strontium-82 has a half-life of 25.5 days while Rubidium-82 has a half-life of 76 seconds. Heart muscles can take up Rubidium-82 efficiently through sodium–potassium pump. Compared with Technetium-99m, Rubidium-82 has higher uptake by the heart muscles. However, Rubidium-82 has lower uptake by heart muscles when compared to N-13 ammonia. But the positron energy emitted by Rubidium-82 is higher than N-13 ammonia and Fluorodeoxyglucose (18F). On the other hand, the positron range (the distance travelled by a positron from its production site until its annihilation with an electron) is longer when compared to other radiopharmaceuticals, causing reduced image resolution.^[2]

Myocardium has higher uptake for N-13 ammonia when compared to Rubidium-82, thus useful for myocardial perfusion imaging. However, its half-life is only 9.96 minutes. Therefore, on-site facilities such as cyclotron and radiochemistry synthesis facilities should be available. There may be patchy uptake if the subject has defects in lateral ventricular wall. N-13 ammonia may occasionally be degraded by liver, thus causing reduced visibility of the inferior wall of the heart. N-13 ammonia uptake by the lungs is minimal.^[2]

Indications

Patients with many risk factors e.g. hypertension, high cholesterol, smoking habit, diabetes, obesity, high stress occupation, family history of heart attack
Patients who are unable to exercise
Patients suspected of heart attack
Patients newly diagnosed with heart failure
Patients with abnormal ECG or treadmill

Requirements

Facility: taking into consideration clinical workflow, as well as regulatory requirements such as requisite shielding from radiation exposure
Capital equipment: PET or PET/CT scanner
Radiopharmaceutical: Rubidium-82 generator system or close access to cyclotron produced isotopes such as Nitrogen-13 ammonia
Personnel: including specially trained physician, radiographers, radiation safety supervisors and optional nursing support
Operations: stress test monitoring, as well as emergency response equipment, processing and review workstations, administrative and support personnel are additional considerations

Related Research Articles

<span class="mw-page-title-main">Positron emission tomography</span> Medical imaging technique

Positron emission tomography (PET) is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption. Different tracers are used for various imaging purposes, depending on the target process within the body.

<span class="mw-page-title-main">Single-photon emission computed tomography</span> Nuclear medicine tomographic imaging technique

Single-photon emission computed tomography is a nuclear medicine tomographic imaging technique using gamma rays. It is very similar to conventional nuclear medicine planar imaging using a gamma camera, but is able to provide true 3D information. This information is typically presented as cross-sectional slices through the patient, but can be freely reformatted or manipulated as required.

Nuclear medicine or nucleology is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear imaging, in a sense, is "radiology done inside out" because it records radiation emitted from within the body rather than radiation that is transmitted through the body from external sources like X-ray generators. In addition, nuclear medicine scans differ from radiology, as the emphasis is not on imaging anatomy, but on the function. For such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine.

A radioactive tracer, radiotracer, or radioactive label is a chemical compound in which one or more atoms have been replaced by a radionuclide so by virtue of its radioactive decay it can be used to explore the mechanism of chemical reactions by tracing the path that the radioisotope follows from reactants to products. Radiolabeling or radiotracing is thus the radioactive form of isotopic labeling. In biological contexts, use of radioisotope tracers are sometimes called radioisotope feeding experiments.

Nitrogen-13 (¹³N) is a radioisotope of nitrogen used in positron emission tomography (PET). It has a half-life of a little under ten minutes, so it must be made at the PET site. A cyclotron may be used for this purpose.

A bone scan or bone scintigraphy is a nuclear medicine imaging technique of the bone. It can help diagnose a number of bone conditions, including cancer of the bone or metastasis, location of bone inflammation and fractures, and bone infection (osteomyelitis).

[¹⁸F]Fluorodeoxyglucose (INN), or fluorodeoxyglucose F 18, also commonly called fluorodeoxyglucose and abbreviated [¹⁸F]FDG, 2-[¹⁸F]FDG or FDG, is a radiopharmaceutical, specifically a radiotracer, used in the medical imaging modality positron emission tomography (PET). Chemically, it is 2-deoxy-2-[¹⁸F]fluoro-D-glucose, a glucose analog, with the positron-emitting radionuclide fluorine-18 substituted for the normal hydroxyl group at the C-2 position in the glucose molecule.

Fluorine-18 (¹⁸F) is a fluorine radioisotope which is an important source of positrons. It has a mass of 18.0009380(6) u and its half-life is 109.771(20) minutes. It decays by positron emission 96% of the time and electron capture 4% of the time. Both modes of decay yield stable oxygen-18.

Rubidium-82 chloride is a form of rubidium chloride containing a radioactive isotope of rubidium. It is marketed under the brand name Cardiogen-82 by Bracco Diagnostics for use in Myocardial perfusion imaging. It is rapidly taken up by heart muscle cells, and therefore can be used to identify regions of heart muscle that are receiving poor blood flow in a technique called PET perfusion imaging. The half-life of the rubidium-82 is only 1.27 minutes; it is normally produced at the place of use by rubidium generators.

A gallium scan is a type of nuclear medicine test that uses either a gallium-67 (⁶⁷Ga) or gallium-68 (⁶⁸Ga) radiopharmaceutical to obtain images of a specific type of tissue, or disease state of tissue. Gallium salts like gallium citrate and gallium nitrate may be used. The form of salt is not important, since it is the freely dissolved gallium ion Ga³⁺ which is active. Both ⁶⁷Ga and ⁶⁸Ga salts have similar uptake mechanisms. Gallium can also be used in other forms, for example ⁶⁸Ga-PSMA is used for cancer imaging. The gamma emission of gallium-67 is imaged by a gamma camera, while the positron emission of gallium-68 is imaged by positron emission tomography (PET).

Myocardial perfusion imaging or scanning is a nuclear medicine procedure that illustrates the function of the heart muscle (myocardium).

Copper-64 (⁶⁴Cu) is a positron and beta emitting isotope of copper, with applications for molecular radiotherapy and positron emission tomography. Its unusually long half-life (12.7-hours) for a positron-emitting isotope makes it increasingly useful when attached to various ligands, for PET and PET-CT scanning.

Positron emission tomography–computed tomography is a nuclear medicine technique which combines, in a single gantry, a positron emission tomography (PET) scanner and an x-ray computed tomography (CT) scanner, to acquire sequential images from both devices in the same session, which are combined into a single superposed (co-registered) image. Thus, functional imaging obtained by PET, which depicts the spatial distribution of metabolic or biochemical activity in the body can be more precisely aligned or correlated with anatomic imaging obtained by CT scanning. Two- and three-dimensional image reconstruction may be rendered as a function of a common software and control system.

Perfusion is the passage of fluid through the lymphatic system or blood vessels to an organ or a tissue. The practice of perfusion scanning is the process by which this perfusion can be observed, recorded and quantified. The term perfusion scanning encompasses a wide range of medical imaging modalities.

Nuclear medicine physicians, also called nuclear radiologists or simply nucleologists, are medical specialists that use tracers, usually radiopharmaceuticals, for diagnosis and therapy. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy. In the United States, nuclear medicine physicians are certified by the American Board of Nuclear Medicine and the American Osteopathic Board of Nuclear Medicine.

Rubidium-82 (⁸²Rb) is a radioactive isotope of rubidium. ⁸²Rb is widely used in myocardial perfusion imaging. This isotope undergoes rapid uptake by myocardiocytes, which makes it a valuable tool for identifying myocardial ischemia in Positron Emission Tomography (PET) imaging. ⁸²Rb is used in the pharmaceutical industry and is marketed as Rubidium-82 chloride under the trade names RUBY-FILL and CardioGen-82.

Cardiac imaging refers to minimally invasive imaging of the heart using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or nuclear medicine (NM) imaging with PET or SPECT. These cardiac techniques are otherwise referred to as echocardiography, Cardiac MRI, Cardiac CT, Cardiac PET and Cardiac SPECT including myocardial perfusion imaging.

Brain positron emission tomography is a form of positron emission tomography (PET) that is used to measure brain metabolism and the distribution of exogenous radiolabeled chemical agents throughout the brain. PET measures emissions from radioactively labeled metabolically active chemicals that have been injected into the bloodstream. The emission data from brain PET are computer-processed to produce multi-dimensional images of the distribution of the chemicals throughout the brain.

<span class="mw-page-title-main">FMISO</span> Chemical compound

¹⁸F-FMISO or fluoromisonidazole is a radiopharmaceutical used for PET imaging of hypoxia. It consists of a 2-nitroimidazole molecule labelled with the positron-emitter fluorine-18.

Oxygen-15 labelled water (also known as ¹⁵O-water, [O-15]-H₂O, or H₂¹⁵O) is a radioactive variation of regular water, in which the oxygen atom has been replaced by oxygen-15 (¹⁵O), a positron-emitting isotope. ¹⁵O-water is used as a radioactive tracer for measuring and quantifying blood flow using positron emission tomography (PET) in the heart, brain and tumors.

References

↑ Ghosh, N; Rimoldi OE; Beanlands RS; Camici PG (December 2010). "Assessment of myocardial ischaemia and viability: role of positron emission tomography". European Heart Journal. 31 (24): 2984–2995. doi:10.1093/eurheartj/ehq361. PMID 20965888.
1 2 3 Di Carli, Marcelo F.; Dondi, Maurizio; Giubbini, Raffaele; Paez, Diana, eds. (2022). IAEA Atlas of Cardiac PET/CT: A Case-Study Approach. Berlin, Heidelberg: Springer Berlin Heidelberg. doi:10.1007/978-3-662-64499-7. ISBN 978-3-662-64498-0. S2CID 248368314.

This nuclear medicine article is a stub. You can help Wikipedia by expanding it.

This article related to medical imaging is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Ghosh, N; Rimoldi OE; Beanlands RS; Camici PG (December 2010). "Assessment of myocardial ischaemia and viability: role of positron emission tomography". European Heart Journal. 31 (24): 2984–2995. doi:10.1093/eurheartj/ehq361. PMID 20965888.

[Di_Carli_2022-2] 1 2 3 Di Carli, Marcelo F.; Dondi, Maurizio; Giubbini, Raffaele; Paez, Diana, eds. (2022). IAEA Atlas of Cardiac PET/CT: A Case-Study Approach. Berlin, Heidelberg: Springer Berlin Heidelberg. doi:10.1007/978-3-662-64499-7. ISBN 978-3-662-64498-0. S2CID 248368314.

[1]

[2]